Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 16,053	$ 14,607
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including a below-market ground lease)	11,906	11,582
Amortization of deferred financing costs	541	484
Amortization of stock-based compensation	994	904
Straight-line rental income	(463)	(591)
Noncash interest income	(10)	(106)
Gain on sale of real estate	0	(2,051)
Change in operating assets and liabilities:
Accounts and other receivables, net	(1,220)	(155)
Prepaid expenses and other assets	(116)	(36)
Accounts payable and accrued liabilities	2,389	(2,579)
Net cash provided by operating activities	30,074	22,059
Cash flows from investing activities:
Acquisitions of real estate	(52,697)	(47,103)
Improvements to real estate	(452)	(11)
Purchases of equipment, furniture and fixtures	(1,806)	(27)
Investment in real estate mortgage and other loans receivable	(11,389)	0
Principal payments received on real estate mortgage and other loans receivable	411	23
Escrow deposits for acquisitions of real estate	(375)	(1,000)
Net proceeds from the sale of real estate	131	13,004
Net cash used in investing activities	(66,177)	(35,114)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	47,260	(10)
Proceeds from the issuance of senior unsecured term loan	200,000	0
Borrowings under unsecured revolving credit facility	185,000	60,000
Payments on senior unsecured term loan	(100,000)	0
Payments on unsecured revolving credit facility	(95,000)	(25,000)
Payments of deferred financing costs	(4,390)	0
Net-settle adjustment on restricted stock	(1,495)	(605)
Dividends paid on common stock	(17,710)	(14,044)
Net cash provided by financing activities	213,665	20,341
Net increase in cash and cash equivalents	177,562	7,286
Cash and cash equivalents, beginning of period	36,792	6,909
Cash and cash equivalents, end of period	214,354	14,195
Supplemental disclosures of cash flow information:
Interest paid	2,242	2,675
Supplemental schedule of noncash investing and financing activities:
Increase in dividends payable	2,303	1,564
Increase in deferred financing costs payable	$ 144	$ 0